# Hemcare of Oregon, Inc. – FDA Inspection, Apr 26, 2017

Source: https://www.keypedia.com/records/fda_inspections/hemcare-of-oregon-inc/ed9c1490-eae0-47c0-8c5c-e610a7e1a475
Source feed: FDA_Inspections

> FDA inspection 1012254 of Hemcare of Oregon, Inc., April 26, 2017. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1012254
- Company Name: Hemcare of Oregon, Inc.
- Inspection Date: 2017-04-26
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Unapproved and Misbranded Drugs
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Documents

- [FDA Inspection 1223333 - 2023-11-03](https://www.keypedia.com/records/fda_inspections/hemcare-of-oregon-inc/a859e095-1efe-4449-aef9-afa661b01c71)
- FDA Inspection 1123523 - 2019-10-11
- [FDA Inspection 814211 - 2013-01-07](https://www.keypedia.com/records/fda_inspections/hemcare-of-oregon-inc/8f52f8f1-d7c7-4f9c-8c05-a23b637da951)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/nancy-e-byerly/836e1285-c6b4-4bfd-bf65-1b76fd551d62)

Company: https://www.keypedia.com/companies/hemcare-of-oregon-inc/57fd2281-8328-4cfc-bfb6-42f1cfb2faa5

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c